Share Price and Basic Stock Data
Last Updated: December 9, 2025, 8:07 pm
| PEG Ratio | 0.58 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ashok Leyland Ltd, a prominent player in the auto sector focusing on light and heavy commercial vehicles, reported a robust financial performance in recent quarters. For the fiscal year ending March 2024, the company recorded sales of ₹45,791 Cr, reflecting a significant recovery from the pandemic lows, as compared to ₹41,673 Cr in the previous year. The trailing twelve months (TTM) sales reached ₹49,547 Cr, showcasing a steady upward trajectory in revenue generation. Notably, the company’s sales in the March 2024 quarter alone peaked at ₹13,542 Cr, indicating a strong demand resurgence. This trend continued into the subsequent quarters, with sales in June 2024 reported at ₹10,724 Cr and September 2024 at ₹11,148 Cr. The company seems well-positioned to leverage the recovery in commercial vehicle demand, driven by infrastructure spending and economic growth dynamics.
Profitability and Efficiency Metrics
Ashok Leyland’s profitability metrics depict a commendable operational efficiency. The operating profit margin (OPM) stood at 19% for the fiscal year ending March 2024, up from 12% in the previous year, indicating improved cost management and pricing power. The net profit for the same period was reported at ₹2,696 Cr, a significant increase from ₹1,359 Cr in FY 2023. This translates to a net profit margin of 6.90%, which, while respectable, can still be improved further. The return on equity (ROE) is another strong point, recorded at 28.8%, which is quite favorable, suggesting that the company is generating substantial returns on shareholders’ investments. Furthermore, the interest coverage ratio (ICR) of 2.43x reflects a manageable debt level, providing a cushion against interest rate fluctuations and enhancing confidence among investors regarding the company’s financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Ashok Leyland appears solid yet carries some elements of concern. The total borrowings surged to ₹54,513 Cr, reflecting a significant increase from ₹40,802 Cr in the previous year. While this escalation in debt can be attributed to investments aimed at expanding production capacity and enhancing operational efficiency, it also raises questions about financial leverage and risk management. The debt-to-equity ratio stands at 4.06x, indicating a high reliance on borrowed funds, which could be a risk in a rising interest rate environment. On the asset side, the company’s book value per share has shown a healthy growth trajectory, reported at ₹41.66 for March 2025. However, the cash conversion cycle (CCC) of -21 days indicates efficient working capital management, as the company is able to convert its investments into cash in a relatively short period.
Shareholding Pattern and Investor Confidence
Ashok Leyland’s shareholding structure reflects a balanced mix of promoter and institutional holdings, which is a positive indicator of investor confidence. Promoters hold 51.51% of the company, ensuring stability in management and long-term vision. Foreign institutional investors (FIIs) have increased their stake to 24.32%, up from 15.29% in December 2022, showing growing confidence from overseas investors. Domestic institutional investors (DIIs) hold 13.59%, which remains steady, indicating a consistent interest from local funds. The number of shareholders has also risen to 14,50,991, suggesting a growing retail interest. However, the public shareholding has decreased slightly, which might indicate a consolidation phase among larger investors. This blend of institutional and retail participation could provide a robust support system for the stock’s performance in the market.
Outlook, Risks, and Final Insight
Looking ahead, Ashok Leyland stands at a crossroads of opportunity and challenges. The company’s strong sales growth driven by infrastructure development and a recovering economy presents a favorable outlook. However, elevated debt levels and a high reliance on external financing could pose risks, particularly if interest rates continue to rise. Additionally, fluctuations in raw material prices, particularly steel and other components essential for vehicle manufacturing, could impact margins. Investors should weigh these factors carefully. The company’s strong operational metrics and improving profitability make it an attractive prospect, yet the balance sheet dynamics necessitate caution. Overall, Ashok Leyland seems poised for growth, but potential investors should remain vigilant about the macroeconomic landscape and its implications for the company’s financial health.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ashok Leyland Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Force Motors Ltd | 22,560 Cr. | 17,112 | 22,000/6,125 | 27.5 | 2,661 | 0.23 % | 30.0 % | 20.8 % | 10.0 |
| SML ISUZU Ltd | 4,611 Cr. | 3,187 | 4,745/1,028 | 32.6 | 307 | 0.56 % | 27.1 % | 36.4 % | 10.0 |
| Olectra Greentech Ltd | 9,890 Cr. | 1,206 | 1,714/974 | 69.2 | 137 | 0.03 % | 20.5 % | 14.3 % | 4.00 |
| Tata Motors Ltd | 1,47,974 Cr. | 402 | 538/324 | 6.84 | 316 | 1.49 % | 20.0 % | 28.1 % | 2.00 |
| Ashok Leyland Ltd | 93,782 Cr. | 160 | 164/95.2 | 28.0 | 21.4 | 1.96 % | 14.3 % | 28.8 % | 1.00 |
| Industry Average | 55,763.40 Cr | 4,413.40 | 32.83 | 688.48 | 0.85% | 22.38% | 25.68% | 5.40 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,470 | 9,600 | 10,400 | 13,203 | 9,691 | 11,429 | 11,093 | 13,542 | 10,724 | 11,148 | 11,995 | 14,696 | 11,709 |
| Expenses | 7,701 | 8,580 | 9,055 | 11,245 | 8,183 | 9,559 | 9,131 | 10,975 | 8,856 | 9,108 | 9,659 | 11,705 | 9,535 |
| Operating Profit | 770 | 1,020 | 1,344 | 1,958 | 1,509 | 1,870 | 1,961 | 2,567 | 1,868 | 2,040 | 2,336 | 2,991 | 2,173 |
| OPM % | 9% | 11% | 13% | 15% | 16% | 16% | 18% | 19% | 17% | 18% | 19% | 20% | 19% |
| Other Income | 5 | 32 | 36 | 97 | 53 | -1 | 46 | 10 | 36 | 245 | 75 | 22 | 103 |
| Interest | 467 | 499 | 545 | 582 | 655 | 715 | 783 | 829 | 904 | 962 | 1,011 | 1,053 | 1,112 |
| Depreciation | 212 | 209 | 220 | 259 | 227 | 227 | 241 | 233 | 235 | 244 | 268 | 340 | 273 |
| Profit before tax | 96 | 344 | 615 | 1,214 | 679 | 927 | 984 | 1,516 | 765 | 1,078 | 1,132 | 1,621 | 891 |
| Tax % | 77% | 46% | 43% | 34% | 14% | 39% | 38% | 38% | 28% | 29% | 28% | 23% | 26% |
| Net Profit | 22 | 186 | 351 | 803 | 584 | 569 | 609 | 934 | 551 | 767 | 820 | 1,246 | 658 |
| EPS in Rs | 0.01 | 0.28 | 0.54 | 1.28 | 0.93 | 0.90 | 0.95 | 1.45 | 0.87 | 1.20 | 1.30 | 1.92 | 1.04 |
Last Updated: August 20, 2025, 1:30 pm
Below is a detailed analysis of the quarterly data for Ashok Leyland Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11,709.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,696.00 Cr. (Mar 2025) to 11,709.00 Cr., marking a decrease of 2,987.00 Cr..
- For Expenses, as of Jun 2025, the value is 9,535.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11,705.00 Cr. (Mar 2025) to 9,535.00 Cr., marking a decrease of 2,170.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 2,173.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,991.00 Cr. (Mar 2025) to 2,173.00 Cr., marking a decrease of 818.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Mar 2025) to 19.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 103.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 103.00 Cr., marking an increase of 81.00 Cr..
- For Interest, as of Jun 2025, the value is 1,112.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,053.00 Cr. (Mar 2025) to 1,112.00 Cr., marking an increase of 59.00 Cr..
- For Depreciation, as of Jun 2025, the value is 273.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 340.00 Cr. (Mar 2025) to 273.00 Cr., marking a decrease of 67.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 891.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,621.00 Cr. (Mar 2025) to 891.00 Cr., marking a decrease of 730.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 26.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 658.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,246.00 Cr. (Mar 2025) to 658.00 Cr., marking a decrease of 588.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.04. The value appears to be declining and may need further review. It has decreased from 1.92 (Mar 2025) to 1.04, marking a decrease of 0.88.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,859 | 15,708 | 21,260 | 22,871 | 29,636 | 33,197 | 21,951 | 19,454 | 26,237 | 41,673 | 45,791 | 42,333 | 49,547 |
| Expenses | 11,437 | 14,191 | 18,281 | 19,826 | 25,387 | 28,287 | 18,718 | 16,992 | 23,472 | 36,580 | 37,848 | 39,327 | 40,007 |
| Operating Profit | 422 | 1,517 | 2,979 | 3,045 | 4,248 | 4,910 | 3,233 | 2,462 | 2,765 | 5,093 | 7,943 | 3,006 | 9,540 |
| OPM % | 4% | 10% | 14% | 13% | 14% | 15% | 15% | 13% | 11% | 12% | 17% | 7% | 19% |
| Other Income | 613 | -106 | -321 | 406 | 190 | 139 | 57 | 207 | -230 | 166 | 73 | 6,607 | 445 |
| Interest | 805 | 872 | 925 | 1,049 | 1,227 | 1,502 | 1,802 | 1,901 | 1,869 | 2,094 | 2,982 | 3,930 | 4,138 |
| Depreciation | 530 | 580 | 524 | 573 | 646 | 676 | 750 | 836 | 866 | 900 | 927 | 1,087 | 1,125 |
| Profit before tax | -300 | -42 | 1,209 | 1,829 | 2,565 | 2,872 | 739 | -67 | -200 | 2,265 | 4,106 | 4,596 | 4,722 |
| Tax % | -23% | 415% | 41% | 11% | 29% | 24% | 38% | 4% | 43% | 40% | 34% | 26% | |
| Net Profit | -222 | -205 | 712 | 1,633 | 1,814 | 2,195 | 460 | -70 | -285 | 1,359 | 2,696 | 3,383 | 3,490 |
| EPS in Rs | -0.31 | 0.24 | 1.20 | 2.79 | 3.01 | 3.54 | 0.57 | -0.28 | -0.61 | 2.11 | 4.23 | 5.29 | 5.46 |
| Dividend Payout % | 0% | 96% | 40% | 28% | 40% | 44% | 44% | -107% | -82% | 62% | 59% | 59% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.66% | 447.32% | 129.35% | 11.08% | 21.00% | -79.04% | -115.22% | -307.14% | 576.84% | 98.38% | 25.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | 439.66% | -317.96% | -118.27% | 9.92% | -100.05% | -36.17% | -191.93% | 883.98% | -478.46% | -72.90% |
Ashok Leyland Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 54% |
| 3 Years: | 284% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 30% |
| 3 Years: | 16% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 15% |
| 3 Years: | 25% |
| Last Year: | 29% |
Last Updated: September 4, 2025, 11:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:58 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 266 | 285 | 285 | 285 | 293 | 294 | 294 | 294 | 294 | 294 | 294 | 294 | 587 |
| Reserves | 3,723 | 4,227 | 4,979 | 6,108 | 7,128 | 8,452 | 7,495 | 7,568 | 7,010 | 8,258 | 8,711 | 11,938 | 11,996 |
| Borrowings | 8,500 | 9,070 | 11,054 | 13,168 | 15,791 | 19,168 | 22,417 | 24,077 | 24,145 | 31,161 | 40,802 | 49,962 | 54,513 |
| Other Liabilities | 5,035 | 6,011 | 5,806 | 7,048 | 10,171 | 11,212 | 7,924 | 10,119 | 12,125 | 14,984 | 17,788 | 19,352 | 18,214 |
| Total Liabilities | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 | 85,310 |
| Fixed Assets | 7,573 | 6,529 | 5,890 | 6,591 | 6,596 | 6,695 | 8,031 | 8,484 | 7,895 | 8,146 | 8,157 | 8,837 | 9,499 |
| CWIP | 297 | 216 | 87 | 244 | 439 | 678 | 574 | 336 | 240 | 268 | 415 | 577 | 1,042 |
| Investments | 1,165 | 1,499 | 1,031 | 1,933 | 4,383 | 1,492 | 960 | 1,096 | 2,652 | 4,852 | 2,329 | 6,610 | 5,547 |
| Other Assets | 8,491 | 11,348 | 15,115 | 17,841 | 21,965 | 30,261 | 28,565 | 32,143 | 32,787 | 41,430 | 56,695 | 65,523 | 69,223 |
| Total Assets | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 | 85,310 |
Below is a detailed analysis of the balance sheet data for Ashok Leyland Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 587.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 293.00 Cr..
- For Reserves, as of Sep 2025, the value is 11,996.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,938.00 Cr. (Mar 2025) to 11,996.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2025, the value is 54,513.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 49,962.00 Cr. (Mar 2025) to 54,513.00 Cr., marking an increase of 4,551.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 18,214.00 Cr.. The value appears to be improving (decreasing). It has decreased from 19,352.00 Cr. (Mar 2025) to 18,214.00 Cr., marking a decrease of 1,138.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 85,310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81,546.00 Cr. (Mar 2025) to 85,310.00 Cr., marking an increase of 3,764.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 9,499.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,837.00 Cr. (Mar 2025) to 9,499.00 Cr., marking an increase of 662.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 577.00 Cr. (Mar 2025) to 1,042.00 Cr., marking an increase of 465.00 Cr..
- For Investments, as of Sep 2025, the value is 5,547.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,610.00 Cr. (Mar 2025) to 5,547.00 Cr., marking a decrease of 1,063.00 Cr..
- For Other Assets, as of Sep 2025, the value is 69,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 65,523.00 Cr. (Mar 2025) to 69,223.00 Cr., marking an increase of 3,700.00 Cr..
- For Total Assets, as of Sep 2025, the value is 85,310.00 Cr.. The value appears strong and on an upward trend. It has increased from 81,546.00 Cr. (Mar 2025) to 85,310.00 Cr., marking an increase of 3,764.00 Cr..
However, the Borrowings (54,513.00 Cr.) are higher than the Reserves (11,996.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 414.00 | -8.00 | -9.00 | -10.00 | -11.00 | -15.00 | -19.00 | -22.00 | -22.00 | -26.00 | -33.00 | -46.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 31 | 25 | 20 | 14 | 30 | 25 | 57 | 45 | 37 | 35 | 29 |
| Inventory Days | 69 | 58 | 50 | 73 | 42 | 52 | 42 | 76 | 53 | 44 | 50 | 49 |
| Days Payable | 116 | 108 | 71 | 85 | 96 | 88 | 90 | 162 | 150 | 96 | 85 | 99 |
| Cash Conversion Cycle | -5 | -19 | 5 | 8 | -39 | -6 | -22 | -30 | -52 | -16 | -0 | -21 |
| Working Capital Days | -45 | -41 | -23 | -21 | -54 | -13 | -31 | -44 | -52 | -34 | -50 | -37 |
| ROCE % | 8% | 17% | 15% | 17% | 16% | 9% | 5% | 6% | 11% | 15% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Large & Midcap Fund | 54,000,000 | 2.15 | 764.26 | 11,000,000 | 2025-12-08 07:28:57 | 390.91% |
| Nippon India Growth Mid Cap Fund | 51,844,304 | 1.78 | 733.75 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 39,000,000 | 1.87 | 551.97 | N/A | N/A | N/A |
| HSBC Midcap Fund | 29,124,300 | 3.33 | 412.2 | N/A | N/A | N/A |
| SBI Flexicap Fund | 23,500,000 | 1.44 | 332.6 | N/A | N/A | N/A |
| HDFC Flexi Cap Fund | 20,500,000 | 0.32 | 290.14 | N/A | N/A | N/A |
| SBI Balanced Advantage Fund | 20,349,493 | 0.75 | 288.01 | 18,247,500 | 2025-12-08 06:40:05 | 11.52% |
| Kotak Multicap Fund | 17,835,000 | 1.17 | 252.42 | N/A | N/A | N/A |
| Franklin India Flexi Cap Fund | 17,710,254 | 1.27 | 250.65 | N/A | N/A | N/A |
| Franklin India Focused Equity Fund | 14,300,000 | 1.6 | 202.39 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| Diluted EPS (Rs.) | 10.56 | 8.45 | 4.22 | -1.22 | -0.56 |
| Cash EPS (Rs.) | 15.11 | 12.29 | 7.67 | 1.95 | 2.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Revenue From Operations / Share (Rs.) | 165.28 | 155.95 | 141.93 | 89.38 | 66.27 |
| PBDIT / Share (Rs.) | 32.58 | 27.53 | 17.72 | 9.72 | 8.84 |
| PBIT / Share (Rs.) | 28.88 | 24.37 | 14.66 | 6.77 | 5.99 |
| PBT / Share (Rs.) | 15.54 | 13.93 | 7.69 | -0.70 | -0.22 |
| Net Profit / Share (Rs.) | 11.41 | 9.13 | 4.60 | -0.99 | -0.23 |
| NP After MI And SOA / Share (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| PBDIT Margin (%) | 19.70 | 17.65 | 12.48 | 10.87 | 13.33 |
| PBIT Margin (%) | 17.47 | 15.62 | 10.32 | 7.56 | 9.03 |
| PBT Margin (%) | 9.40 | 8.93 | 5.41 | -0.78 | -0.34 |
| Net Profit Margin (%) | 6.90 | 5.85 | 3.24 | -1.11 | -0.35 |
| NP After MI And SOA Margin (%) | 6.40 | 5.42 | 2.97 | -1.36 | -0.84 |
| Return on Networth / Equity (%) | 25.39 | 27.58 | 14.50 | -4.90 | -2.10 |
| Return on Capital Employeed (%) | 15.37 | 17.46 | 13.33 | 7.94 | 6.80 |
| Return On Assets (%) | 3.80 | 3.67 | 2.26 | -0.82 | -0.39 |
| Long Term Debt / Equity (X) | 2.97 | 2.96 | 2.28 | 2.09 | 1.98 |
| Total Debt / Equity (X) | 4.06 | 4.51 | 3.61 | 3.28 | 2.31 |
| Asset Turnover Ratio (%) | 0.64 | 0.74 | 0.84 | 0.69 | 0.54 |
| Current Ratio (X) | 1.29 | 1.09 | 1.08 | 0.99 | 0.98 |
| Quick Ratio (X) | 1.14 | 0.94 | 0.92 | 0.86 | 0.82 |
| Inventory Turnover Ratio (X) | 12.14 | 7.58 | 9.45 | 6.96 | 6.04 |
| Dividend Payout Ratio (NP) (%) | 18.90 | 89.26 | 23.65 | -49.11 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.00 | 64.99 | 13.71 | 34.71 | 0.00 |
| Earning Retention Ratio (%) | 81.10 | 10.74 | 76.35 | 149.11 | 0.00 |
| Cash Earning Retention Ratio (%) | 86.00 | 35.01 | 86.29 | 65.29 | 0.00 |
| Interest Coverage Ratio (X) | 2.43 | 2.71 | 2.49 | 1.53 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.85 | 1.93 | 1.62 | 1.02 | 0.92 |
| Enterprise Value (Cr.) | 106013.76 | 86549.03 | 71834.36 | 57544.92 | 50957.36 |
| EV / Net Operating Revenue (X) | 2.18 | 1.89 | 1.72 | 2.19 | 2.62 |
| EV / EBITDA (X) | 11.08 | 10.71 | 13.80 | 20.18 | 19.65 |
| MarketCap / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| Retention Ratios (%) | 81.09 | 10.73 | 76.34 | 149.11 | 0.00 |
| Price / BV (X) | 4.90 | 5.58 | 4.78 | 4.71 | 4.24 |
| Price / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| EarningsYield | 0.05 | 0.04 | 0.03 | -0.01 | 0.00 |
After reviewing the key financial ratios for Ashok Leyland Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.56. This value is within the healthy range. It has increased from 8.45 (Mar 24) to 10.56, marking an increase of 2.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.11. This value is within the healthy range. It has increased from 12.29 (Mar 24) to 15.11, marking an increase of 2.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.28. It has increased from 155.95 (Mar 24) to 165.28, marking an increase of 9.33.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.58. This value is within the healthy range. It has increased from 27.53 (Mar 24) to 32.58, marking an increase of 5.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.88. This value is within the healthy range. It has increased from 24.37 (Mar 24) to 28.88, marking an increase of 4.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.54. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 15.54, marking an increase of 1.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 11.41, marking an increase of 2.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For PBDIT Margin (%), as of Mar 25, the value is 19.70. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 19.70, marking an increase of 2.05.
- For PBIT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 15.62 (Mar 24) to 17.47, marking an increase of 1.85.
- For PBT Margin (%), as of Mar 25, the value is 9.40. This value is below the healthy minimum of 10. It has increased from 8.93 (Mar 24) to 9.40, marking an increase of 0.47.
- For Net Profit Margin (%), as of Mar 25, the value is 6.90. This value is within the healthy range. It has increased from 5.85 (Mar 24) to 6.90, marking an increase of 1.05.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.40. This value is below the healthy minimum of 8. It has increased from 5.42 (Mar 24) to 6.40, marking an increase of 0.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.39. This value is within the healthy range. It has decreased from 27.58 (Mar 24) to 25.39, marking a decrease of 2.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.37. This value is within the healthy range. It has decreased from 17.46 (Mar 24) to 15.37, marking a decrease of 2.09.
- For Return On Assets (%), as of Mar 25, the value is 3.80. This value is below the healthy minimum of 5. It has increased from 3.67 (Mar 24) to 3.80, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 2.97. This value exceeds the healthy maximum of 1. It has increased from 2.96 (Mar 24) to 2.97, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 4.06. This value exceeds the healthy maximum of 1. It has decreased from 4.51 (Mar 24) to 4.06, marking a decrease of 0.45.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.74 (Mar 24) to 0.64, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 1.5. It has increased from 1.09 (Mar 24) to 1.29, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 1.14, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.14. This value exceeds the healthy maximum of 8. It has increased from 7.58 (Mar 24) to 12.14, marking an increase of 4.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.90. This value is below the healthy minimum of 20. It has decreased from 89.26 (Mar 24) to 18.90, marking a decrease of 70.36.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.00. This value is below the healthy minimum of 20. It has decreased from 64.99 (Mar 24) to 14.00, marking a decrease of 50.99.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.10. This value exceeds the healthy maximum of 70. It has increased from 10.74 (Mar 24) to 81.10, marking an increase of 70.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.00. This value exceeds the healthy maximum of 70. It has increased from 35.01 (Mar 24) to 86.00, marking an increase of 50.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.71 (Mar 24) to 2.43, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 3. It has decreased from 1.93 (Mar 24) to 1.85, marking a decrease of 0.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 106,013.76. It has increased from 86,549.03 (Mar 24) to 106,013.76, marking an increase of 19,464.73.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.18, marking an increase of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 11.08. This value is within the healthy range. It has increased from 10.71 (Mar 24) to 11.08, marking an increase of 0.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For Retention Ratios (%), as of Mar 25, the value is 81.09. This value exceeds the healthy maximum of 70. It has increased from 10.73 (Mar 24) to 81.09, marking an increase of 70.36.
- For Price / BV (X), as of Mar 25, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.58 (Mar 24) to 4.90, marking a decrease of 0.68.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ashok Leyland Ltd:
- Net Profit Margin: 6.9%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.37% (Industry Average ROCE: 22.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.39% (Industry Average ROE: 25.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.14
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28 (Industry average Stock P/E: 32.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 4.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.9%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto - LCVs/HCVs | No.1, Sardar Patel Road, Guindy, Chennai (Madras) Tamil Nadu 600032 | reachus@ashokleyland.com http://www.ashokleyland.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dheeraj G Hinduja | Executive Chairman |
| Mr. Shenu Agarwal | Managing Director & CEO |
| Mr. Shom Ashok Hinduja | Director |
| Ms. Sanjay K Asher | Director |
| Mr. Manisha Girotra | Director |
| Mr. Gopal Mahadevan | Director |
| Mr. Jose Maria Alapont | Director |
| Mr. Saugata Gupta | Director |
| Dr. C Bhaktavatsala Rao | Director |
| Dr. V Sumantran | Director |
| Mr. Thomas Dauner | Director |
| Mr. Sven Christoph Ennerst | Director |
FAQ
What is the intrinsic value of Ashok Leyland Ltd?
Ashok Leyland Ltd's intrinsic value (as of 09 December 2025) is 140.76 which is 12.03% lower the current market price of 160.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 93,782 Cr. market cap, FY2025-2026 high/low of 164/95.2, reserves of ₹11,996 Cr, and liabilities of 85,310 Cr.
What is the Market Cap of Ashok Leyland Ltd?
The Market Cap of Ashok Leyland Ltd is 93,782 Cr..
What is the current Stock Price of Ashok Leyland Ltd as on 09 December 2025?
The current stock price of Ashok Leyland Ltd as on 09 December 2025 is 160.
What is the High / Low of Ashok Leyland Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ashok Leyland Ltd stocks is 164/95.2.
What is the Stock P/E of Ashok Leyland Ltd?
The Stock P/E of Ashok Leyland Ltd is 28.0.
What is the Book Value of Ashok Leyland Ltd?
The Book Value of Ashok Leyland Ltd is 21.4.
What is the Dividend Yield of Ashok Leyland Ltd?
The Dividend Yield of Ashok Leyland Ltd is 1.96 %.
What is the ROCE of Ashok Leyland Ltd?
The ROCE of Ashok Leyland Ltd is 14.3 %.
What is the ROE of Ashok Leyland Ltd?
The ROE of Ashok Leyland Ltd is 28.8 %.
What is the Face Value of Ashok Leyland Ltd?
The Face Value of Ashok Leyland Ltd is 1.00.